Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TERF2IP | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-06 |
mRNA | DSG2 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-06 |
mRNA | GRHL1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
mRNA | PROM2 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-06 |
mRNA | PRPS1 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
mRNA | FAM83B | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-06 |
mRNA | TTC22 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
mRNA | SUMF2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | SLC35A4 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
mRNA | SERPINE2 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |